878197-67-2

Basic information

• Product Name: 5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE
• Synonyms: 5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE;5-Fluoroimidazo[1,2-a]pyridine-2-carbaldehyde;5-Fluoro-2-formylimidazo[1,2-a]pyridine
• CAS NO: 878197-67-2
• Molecular Formula: C₈H₅FN₂O
• Molecular Weight: 164.139
• Mol File: 878197-67-2.mol

Chemical Properties

• Appearance: /
• Density: 1.369 g/cm³
• Refractive Index: 1.618
• CAS DataBase Reference: 5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE(878197-67-2)
• EPA Substance Registry System: 5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE(878197-67-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 878197-67-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and reactivity contribute to the development of new drugs, enhancing the therapeutic potential of medications in treating diverse health conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE is utilized as a vital component in the production of agrochemicals. Its incorporation aids in the development of effective pesticides and other agricultural chemicals, thereby supporting crop protection and yield enhancement.
Used in Organic Synthesis:
5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE is employed as a versatile building block in organic synthesis. Its distinctive structure allows for the creation of a wide range of chemical products, expanding the scope of chemical research and innovation.

InChI:InChI=1/C8H5FN2O/c9-7-2-1-3-8-10-6(5-12)4-11(7)8/h1-5H

Upstream product

• 921-03-9 1,1,3-trichloroacetone 
• 1597-32-6 6-fluoro-pyridin-2-ylamine 
• 918-00-3 1,1,1-trichloroacetone 
• 878197-91-2 2-(dichloromethyl)-5-fluoroimidazo[1,2-a]pyridine 

Downstream Products

• 878197-92-3 (5-fluoroimidazo[1,2-a]pyridin-2-yl)methanol 
• 1428968-93-7 2-(5-fluoroimidazo[1,2-a]pyridin-2-yl)-1-(1H-indol-3-yl)-2-((3-methoxyphenyl)amino)ethanone 
• 1428972-64-8 N-((5-fluoroimidazo[1,2-a]pyridin-2-yl)methylene)-3-methoxyaniline 
• 878198-42-6 (8S)-N-[(5-fluoroimidazo[1,2-a]pyridin-2-yl)methyl]-N-{(1S)-1-[4-(methyloxy)phenyl]ethyl}-5,6,7,8-tetrahydro-8-quinolinamine 

Relevant articles and documents

Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1

Synthesis of several novel imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV are described. Synthetic approaches allowing for variation of the substitution pattern are outlined and resulting changes in antivir

Kilogram-scale synthesis of the CXCR4 antagonist GSK812397

An improved, scalable synthesis of the CXCR4 antagonist GSK812397 is described. This new route was recently scaled up in 50 L fixed equipment to afford 1.2 kg of drug substance in five steps with an overall yield of 20% and >99% chemical and enantiomeric

CHEMICAL COMPOUNDS

The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a

CHEMICAL COMPOUNDS

The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a

CHEMICAL COMPOUNDS

There is provided novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as C

CHEMCIAL COMPOUNDS

The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.

CHEMICAL COMPOUNDS

The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a recep

CHEMICAL COMPOUNDS

The present invention provides compounds of Formula (I) comprising: including salts, solvates, and physiologically functional derivatives thereof, pharmaceutical formulations containing them, processes for their preparation, and methods of treatment using them.